Literature DB >> 9070732

Future pregnancy outcome in unexplained recurrent first trimester miscarriage.

K Clifford1, R Rai, L Regan.   

Abstract

The future pregnancy outcome of 201 consecutive women, median age 34 years (range 22-43), with a history of unexplained recurrent first trimester miscarriage (median 3; range 3-13), was studied. All women and their partners had normal peripheral blood karyotypes; none had antiphospholipid antibodies and none hypersecreted luteinizing hormone (LH). No pharmacological treatment was prescribed and early pregnancy supportive care was encouraged. Women aged < or = 30 years had a subsequent miscarriage rate of 25% (14/57) which rose to 52% (13/25) in women aged > or = 40 years (P = 0.02). After three consecutive miscarriages, the risk of miscarriage of the next pregnancy was 29% (34/119) but increased to 53% (9/17) after six or more previous losses (P = 0.04). A past history of a livebirth did not influence the outcome of the next pregnancy. Supportive care in early pregnancy conferred a significant beneficial effect on pregnancy outcome. Of 160 women who attended the early pregnancy clinic, 42 (26%) miscarried in the next pregnancy compared with 21 out of 41 (51%) who did not attend the clinic (P = 0.002). After thorough investigation, women with unexplained recurrent first trimester miscarriage have an excellent pregnancy outcome without pharmacological intervention if offered supportive care alone in the setting of a dedicated miscarriage clinic.

Entities:  

Mesh:

Year:  1997        PMID: 9070732     DOI: 10.1093/humrep/12.2.387

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  30 in total

Review 1.  Natural killer cells, miscarriage, and infertility.

Authors:  Ashley Moffett; Lesley Regan; Peter Braude
Journal:  BMJ       Date:  2004-11-27

2.  Investigation of recurrent miscarriages.

Authors:  Fred Kavalier
Journal:  BMJ       Date:  2005-07-16

Review 3.  Intravenous immunoglobulin and recurrent pregnancy loss.

Authors:  Howard J A Carp; Tal Sapir; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2005-12       Impact factor: 8.667

4.  Recurrent pregnancy loss: etiology, diagnosis, and therapy.

Authors:  Holly B Ford; Danny J Schust
Journal:  Rev Obstet Gynecol       Date:  2009

5.  Acupuncture as a therapeutic treatment option for threatened miscarriage.

Authors:  Debra Betts; Caroline A Smith; Dahlen G Hannah
Journal:  BMC Complement Altern Med       Date:  2012-03-22       Impact factor: 3.659

6.  Are expanded alleles of the FMR1 gene related to unexplained recurrent miscarriages?

Authors:  M Fragkos; H Bili; D Ntelios; G Tzimagiorgis; B C Tarlatzis
Journal:  Hippokratia       Date:  2018 Jul-Sep       Impact factor: 0.471

7.  Genetic evaluation and counseling of couples with recurrent miscarriage: recommendations of the National Society of Genetic Counselors.

Authors:  Mercy Y Laurino; Robin L Bennett; Devki S Saraiya; Lisa Baumeister; Debra Lochner Doyle; Kathleen Leppig; Barbara Pettersen; Robert Resta; Larry Shields; Stefanie Uhrich; Elizabeth A Varga; Wendy H Raskind
Journal:  J Genet Couns       Date:  2005-06       Impact factor: 2.537

8.  Positive association of Apolipoprotein E4 polymorphism with recurrent pregnancy loss in Iranian patients.

Authors:  Nooshin Asgari; Mohammad Taghi Akbari; Shohre Zare; Gholamreza Babamohammadi
Journal:  J Assist Reprod Genet       Date:  2013-01-08       Impact factor: 3.412

Review 9.  Stress and reproductive failure: past notions, present insights and future directions.

Authors:  Katrina Nakamura; Sam Sheps; Petra Clara Arck
Journal:  J Assist Reprod Genet       Date:  2008-02-15       Impact factor: 3.412

10.  Apolipoprotein E (Apo E) gene polymorphisms and recurrent pregnancy loss: a meta-analysis.

Authors:  Jie Li; Yang Chen; Hongbo Wu; Liuming Li
Journal:  J Assist Reprod Genet       Date:  2013-11-13       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.